Disclosed herein are crystalline forms of L-ornithine phenyl acetate and methods of making the same. The crystalline form may, in some embodiments, be Forms I, II, III and V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
本文披露了
L-鸟氨酸苯乙酸盐的晶体形式及其制备方法。在某些实施例中,晶体形式可以是I、II、III和V形式,或其混合物。晶体形式可以用于治疗肝脏疾病,如肝性脑病的患者。因此,某些实施例包括
L-鸟氨酸苯乙酸盐的制剂和给药方法。